I was wondering when this would come up in this thread. MERCK Co. is currently in phase 3 trials of what appears to be a successful antiviral for Sars CoV-2. If/when it gets approved (from what I’ve read it’s looking good), it’ll be a game changer considering the vaccines are less than a year old.